Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 18 December 2012
[DOI: 10.1126/scisignal.2003184]

Supplementary Materials for:

IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors

Valentina Evdokimova, Cristina E. Tognon, Tania Benatar, Wenyi Yang, Konstantin Krutikov, Michael Pollak, Poul H. B. Sorensen, Arun Seth*

*To whom correspondence should be addressed. E-mail: arun.seth{at}utoronto.ca

This PDF file includes:

  • Fig. S1. IGFBP7 does not interfere with activation of the IGF1R or INSR pathways when added simultaneously with their cognate ligands.
  • Fig. S2. Pretreatment with IGFBP7 or its ectopic expression in cancer cell lines inhibits IGF-1–mediated activation of IGF1R.
  • Fig. S3. Plasma membrane localization of IGFBP7 in treated or transfected cell lines.
  • Fig. S4. Full-length but not the truncated form of IGFBP7 induces apoptosis in the absence of IGF-1.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 924 KB


Citation: V. Evdokimova, C. E. Tognon, T. Benatar, W. Yang, K. Krutikov, M. Pollak, P. H. B. Sorensen, A. Seth, IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors. Sci. Signal. 5, ra92 (2012).

© 2012 American Association for the Advancement of Science


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882